JP2010513478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513478A5 JP2010513478A5 JP2009542710A JP2009542710A JP2010513478A5 JP 2010513478 A5 JP2010513478 A5 JP 2010513478A5 JP 2009542710 A JP2009542710 A JP 2009542710A JP 2009542710 A JP2009542710 A JP 2009542710A JP 2010513478 A5 JP2010513478 A5 JP 2010513478A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound
- indazol
- copd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000004537 indazol-5-yl group Chemical group N1N=CC2=CC(=CC=C12)* 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87118406P | 2006-12-21 | 2006-12-21 | |
| US60/871,184 | 2006-12-21 | ||
| US94174507P | 2007-06-04 | 2007-06-04 | |
| US60/941,745 | 2007-06-04 | ||
| US97852607P | 2007-10-09 | 2007-10-09 | |
| US60/978,526 | 2007-10-09 | ||
| PCT/SE2007/001136 WO2008076048A1 (en) | 2006-12-21 | 2007-12-20 | Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012184346A Division JP2012224647A (ja) | 2006-12-21 | 2012-08-23 | グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513478A JP2010513478A (ja) | 2010-04-30 |
| JP2010513478A5 true JP2010513478A5 (en:Method) | 2012-10-11 |
| JP5119267B2 JP5119267B2 (ja) | 2013-01-16 |
Family
ID=39536557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542710A Expired - Fee Related JP5119267B2 (ja) | 2006-12-21 | 2007-12-20 | グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体 |
| JP2012184346A Pending JP2012224647A (ja) | 2006-12-21 | 2012-08-23 | グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012184346A Pending JP2012224647A (ja) | 2006-12-21 | 2012-08-23 | グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体 |
Country Status (36)
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH081035Y2 (ja) | 1993-06-30 | 1996-01-17 | 伸夫 高橋 | 家庭用雑排水の処理装置 |
| FR2866886B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique |
| TW200829578A (en) | 2006-11-23 | 2008-07-16 | Astrazeneca Ab | Chemical compounds 537 |
| JO2754B1 (en) * | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| WO2009142588A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) a chemokine receptor 1 (ccr1) antagonist and (b) glucocorticoid receptor modulator |
| WO2009142568A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) glucocorticoid receptor modulator and (b) a b2-agonist |
| WO2009142589A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| US20100080786A1 (en) * | 2008-05-20 | 2010-04-01 | Markus Berger | Phenyl or Pyridinyl Substituted Indazoles Derivatives |
| WO2010008341A1 (en) * | 2008-07-16 | 2010-01-21 | Astrazeneca Ab | A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| WO2010138421A1 (en) * | 2009-05-27 | 2010-12-02 | Merck Sharp & Dohme Corp. | HEXAHYDROCYCLOPENTYL[f]INDAZOLE REVERSED AMIDES AND DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| WO2011119518A1 (en) * | 2010-03-25 | 2011-09-29 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
| GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
| GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
| EP2726464A1 (en) | 2011-06-29 | 2014-05-07 | Astrazeneca AB | Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| EP3057428A4 (en) | 2013-10-17 | 2017-05-17 | Dow AgroSciences LLC | Processes for the preparation of pesticidal compounds |
| WO2015058022A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| WO2015058028A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| MX2016004945A (es) | 2013-10-17 | 2016-06-28 | Dow Agrosciences Llc | Procesos para la preparacion de compuestos plaguicidas. |
| WO2015058026A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CN105636440A (zh) | 2013-10-17 | 2016-06-01 | 美国陶氏益农公司 | 制备杀虫化合物的方法 |
| BR112016007518A2 (pt) | 2013-10-17 | 2017-08-01 | Dow Agrosciences Llc | processos para a preparação de compostos pesticidas |
| AR098108A1 (es) | 2014-07-31 | 2016-05-04 | Dow Agrosciences Llc | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina |
| AR098107A1 (es) | 2014-07-31 | 2016-05-04 | Dow Agrosciences Llc | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina |
| AR098110A1 (es) | 2014-07-31 | 2016-05-04 | Dow Agrosciences Llc | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina |
| KR20170042714A (ko) | 2014-08-19 | 2017-04-19 | 다우 아그로사이언시즈 엘엘씨 | 3-(3-클로로-1h-피라졸-1-일)피리딘의 제조 방법 |
| BR112017004613A2 (pt) | 2014-09-12 | 2017-12-05 | Dow Agrosciences Llc | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina |
| FR3026105B1 (fr) * | 2014-09-24 | 2019-04-19 | Greenpharma | Composition contenant au moins un inhibiteur de certaines chimiokines, son procede d'obtention et son utilisation dermocosmetique ou pharmaceutique |
| US10196374B2 (en) * | 2014-09-26 | 2019-02-05 | Astrazeneca Ab | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as SGRM modulators |
| WO2017046096A1 (en) * | 2015-09-15 | 2017-03-23 | Leo Pharma A/S | Non-steroidal glucocorticoid receptor modulators for local drug delivery |
| WO2017161518A1 (en) * | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| US10233155B2 (en) | 2016-12-29 | 2019-03-19 | Dow Agrosciences Llc | Processes for the preparation of pesticide compounds |
| EP3562807B1 (en) | 2016-12-29 | 2022-08-03 | Corteva Agriscience LLC | Processes for the preparation of pesticidal compounds |
| TW201927769A (zh) * | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ｉｉ |
| ES2925198T3 (es) | 2017-12-18 | 2022-10-14 | Gruenenthal Gmbh | Amidas de pirrolidinas sustituidas I |
| PE20211733A1 (es) | 2019-01-11 | 2021-09-06 | Gruenenthal Chemie | Amidas de pirrolidina sustituidas |
| ES2980934T3 (es) | 2019-01-22 | 2024-10-03 | Akribes Biomedical Gmbh | Modificadores selectivos del receptor de glucocorticoides para tratar la cicatrización alterada de heridas en la piel |
| WO2020254552A2 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides v |
| ES2946888T3 (es) | 2019-06-19 | 2023-07-27 | Gruenenthal Gmbh | Pirrolidina-amidas sustituidas IV |
| CN114929684B (zh) * | 2019-12-31 | 2023-08-18 | 南京明德新药研发有限公司 | 苯并吡唑类化合物 |
| WO2022008705A1 (en) | 2020-07-09 | 2022-01-13 | Grünenthal GmbH | Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor |
| CN117616020A (zh) * | 2021-06-28 | 2024-02-27 | 南京明德新药研发有限公司 | 一种三唑并吡啶取代的吲唑类化合物的晶型及其制备方法 |
| KR102571432B1 (ko) * | 2023-02-08 | 2023-08-29 | 주식회사 에스씨엘테라퓨틱스 | 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물 |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3992441A (en) | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
| DE3000377A1 (de) | 1980-01-07 | 1981-07-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| DE3514696A1 (de) | 1985-04-24 | 1986-11-06 | Bayer Ag, 5090 Leverkusen | N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung |
| DE3535167A1 (de) | 1985-10-02 | 1987-04-09 | Boehringer Mannheim Gmbh | Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel |
| DE3632329A1 (de) | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
| TW224462B (en:Method) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
| NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| CA2114981A1 (en) | 1993-02-09 | 1994-08-10 | Kazumi Ogata | Quinolonecarboxylic acid derivatives |
| DE4323916A1 (de) | 1993-07-16 | 1995-01-19 | Basf Ag | Substituierte 2-Phenylpyridine |
| ATE225334T1 (de) | 1993-07-26 | 2002-10-15 | Eisai Co Ltd | Sulfonamide und sulfonsäure-ester mit je einem trizyclischen heteroring |
| GB9504854D0 (en) | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
| US5545669A (en) | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
| GB9417532D0 (en) | 1994-08-31 | 1994-10-19 | Zeneca Ltd | Aromatic compounds |
| WO1996036595A1 (en) | 1995-05-19 | 1996-11-21 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| TW542822B (en) | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
| ZA9811898B (en) | 1997-12-29 | 2000-06-28 | Ortho Mcneil Pharm Inc | Anti-Inflammatory Compounds. |
| WO1999038845A1 (en) | 1998-01-29 | 1999-08-05 | Tularik Inc. | Ppar-gamma modulators |
| DE19856475A1 (de) | 1998-11-27 | 2000-05-31 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| KR20020002501A (ko) | 1999-05-13 | 2002-01-09 | 시오노 요시히코 | 당뇨병의 예방 또는 치료약 |
| US6569885B1 (en) | 1999-12-23 | 2003-05-27 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
| ATE281431T1 (de) | 2000-09-11 | 2004-11-15 | Pfizer Prod Inc | Resorcin-derivate |
| FR2815030A1 (fr) | 2000-10-05 | 2002-04-12 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments |
| MXPA04002070A (es) * | 2001-09-19 | 2004-06-07 | Pharmacia Corp | Compuestos de indazol sustituidos para el tratamiento de la inflamacion. |
| AU2002334733B2 (en) | 2001-10-01 | 2006-11-23 | Arena Pharmaceuticals, Inc. | MCH receptors antagonists |
| CN1578767A (zh) | 2001-11-22 | 2005-02-09 | 小野药品工业株式会社 | 哌啶－2－酮衍生化合物及包含其作为活性成分的药学组合物 |
| AU2003209727B2 (en) | 2002-03-13 | 2008-10-16 | Janssen Pharmaceutica N.V. | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| US7282591B2 (en) | 2002-04-11 | 2007-10-16 | Merck & Co., Inc. | 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| CA2784937A1 (en) | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| NL1021182C2 (nl) * | 2002-07-30 | 2004-02-03 | Xpar Vision B V | Analysesysteem en werkwijze voor het analyseren en controleren van een productieproces voor glasproducten. |
| US20050113450A1 (en) | 2002-08-23 | 2005-05-26 | Atli Thorarensen | Antibacterial agents |
| CA2496580A1 (en) * | 2002-08-29 | 2004-03-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | 3-(sulfonamidoethyl)-indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| US6894061B2 (en) | 2002-12-04 | 2005-05-17 | Wyeth | Substituted dihydrophenanthridinesulfonamides |
| CA2767153A1 (en) | 2003-02-20 | 2004-09-02 | Encysive Pharmaceuticals Inc. | Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| US20040235892A1 (en) | 2003-05-22 | 2004-11-25 | Yujia Dai | Indazole and benzisoxazole kinase inhibitors |
| US7297709B2 (en) | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| EP1635800A2 (en) | 2003-06-10 | 2006-03-22 | Kalypsys, Inc. | Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| WO2005004810A2 (en) | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Arylsulfonamide derivatives |
| BRPI0417687A (pt) | 2003-12-19 | 2007-04-03 | Pfizer | derivados de benzenossulfonilamino-piridin-2-ila e compostos relacionados como inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 (11-beta-hsd-1) para o tratamento de diabetes e obesidade |
| JP2005263787A (ja) | 2004-02-17 | 2005-09-29 | Ishihara Sangyo Kaisha Ltd | アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤 |
| US20050250820A1 (en) | 2004-03-08 | 2005-11-10 | Amgen Inc. | Therapeutic modulation of PPARgamma activity |
| DE102004028862A1 (de) * | 2004-06-15 | 2005-12-29 | Merck Patent Gmbh | 3-Aminoindazole |
| US20090093485A1 (en) | 2004-10-29 | 2009-04-09 | Astrazeneca Ab | Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Astrazeneca Ab | Chemical compounds |
| US8093281B2 (en) * | 2005-04-14 | 2012-01-10 | Glaxo Group Limited | Indazoles as glucocorticoid receptor ligands |
| JP2008543780A (ja) * | 2005-06-10 | 2008-12-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルココルチコイド模倣薬、それらの製造方法、医薬組成物及びそれらの使用 |
| US7888381B2 (en) | 2005-06-14 | 2011-02-15 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof |
| TW200815361A (en) | 2005-10-20 | 2008-04-01 | Astrazeneca Ab | Chemical compounds |
| GB0522880D0 (en) | 2005-11-09 | 2005-12-21 | Glaxo Group Ltd | Novel compounds |
| US20090170898A1 (en) | 2006-03-31 | 2009-07-02 | Malena Bengtsson | Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor |
| EA200801997A1 (ru) | 2006-04-20 | 2009-04-28 | Глаксо Груп Лимитед | Новые соединения |
| US8101760B2 (en) | 2006-07-14 | 2012-01-24 | Eli Lilly And Company | Glucocorticoid receptor modulator and methods of use |
| GB0620385D0 (en) | 2006-10-13 | 2006-11-22 | Glaxo Group Ltd | Novel compounds |
| GB0620406D0 (en) | 2006-10-13 | 2006-11-22 | Glaxo Group Ltd | Novel compounds |
| WO2008051532A1 (en) | 2006-10-23 | 2008-05-02 | Merck & Co., Inc. | 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| EP2094692B1 (en) | 2006-11-01 | 2012-11-28 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| US8198311B2 (en) | 2006-11-01 | 2012-06-12 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| TW200829578A (en) | 2006-11-23 | 2008-07-16 | Astrazeneca Ab | Chemical compounds 537 |
| MX2009005264A (es) | 2006-12-06 | 2009-05-28 | Boehringer Ingelheim Int | Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos. |
| JO2754B1 (en) | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| WO2008079073A1 (en) | 2006-12-22 | 2008-07-03 | Astrazeneca Ab | Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| EP2136634A4 (en) | 2007-04-10 | 2011-07-06 | Boehringer Ingelheim Int | GLUCOCORTICOID MIMETICS, METHOD FOR THE MANUFACTURE THEREOF, PHARMACEUTICAL COMPOSITIONS AND THEIR USE |
| CA2683653A1 (en) | 2007-04-10 | 2008-10-16 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| GB0708858D0 (en) | 2007-05-08 | 2007-06-13 | Glaxo Group Ltd | Novel compounds |
| GB0720546D0 (en) | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0720557D0 (en) | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0720556D0 (en) | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0720544D0 (en) | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0720549D0 (en) | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0722211D0 (en) | 2007-11-12 | 2007-12-27 | Glaxo Group Ltd | Novel compounds |
| GB0724254D0 (en) | 2007-12-12 | 2008-01-23 | Glaxo Group Ltd | Novel compounds |
| EP2268630A4 (en) | 2008-02-26 | 2011-03-09 | Merck Sharp & Dohme | HEXAHYDROCYCLOPENTYL [F] INDAZOLCARBOXYL ACID AMIDES AND THEIR DERIVATIVES AS SELECTIVE MODULATORS OF THE GLUCOCORTICOID RECEPTOR |
| JP2011513409A (ja) | 2008-03-06 | 2011-04-28 | メルク・シャープ・エンド・ドーム・コーポレイション | 選択的グルココルチコイドレセプターモジュレーターとしてのヘキサヒドロシクロペンチル［ｆ］インダゾールスルホンアミドおよびこれらの誘導体 |
| US20100080786A1 (en) | 2008-05-20 | 2010-04-01 | Markus Berger | Phenyl or Pyridinyl Substituted Indazoles Derivatives |
| WO2010008341A1 (en) * | 2008-07-16 | 2010-01-21 | Astrazeneca Ab | A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
-
2007
- 2007-12-17 JO JO2007553A patent/JO2754B1/en active
- 2007-12-20 JP JP2009542710A patent/JP5119267B2/ja not_active Expired - Fee Related
- 2007-12-20 KR KR1020097015234A patent/KR20090091354A/ko not_active Ceased
- 2007-12-20 WO PCT/SE2007/001136 patent/WO2008076048A1/en not_active Ceased
- 2007-12-20 CN CN200780051662XA patent/CN101611015B/zh not_active Expired - Fee Related
- 2007-12-20 EP EP07852132A patent/EP2102169B1/en active Active
- 2007-12-20 TW TW096148902A patent/TWI417094B/zh not_active IP Right Cessation
- 2007-12-20 MX MX2009006540A patent/MX2009006540A/es active IP Right Grant
- 2007-12-20 MY MYPI20092610A patent/MY153270A/en unknown
- 2007-12-20 ES ES07852132T patent/ES2387584T3/es active Active
- 2007-12-20 RS RS20120358A patent/RS52411B/sr unknown
- 2007-12-20 PT PT07852132T patent/PT2102169E/pt unknown
- 2007-12-20 HR HRP20120656TT patent/HRP20120656T1/hr unknown
- 2007-12-20 NZ NZ577186A patent/NZ577186A/en not_active IP Right Cessation
- 2007-12-20 UY UY30824A patent/UY30824A1/es not_active Application Discontinuation
- 2007-12-20 PL PL07852132T patent/PL2102169T3/pl unknown
- 2007-12-20 AU AU2007334659A patent/AU2007334659B2/en not_active Ceased
- 2007-12-20 DK DK07852132.5T patent/DK2102169T3/da active
- 2007-12-20 US US12/005,066 patent/US7728030B2/en not_active Expired - Fee Related
- 2007-12-20 CA CA002673277A patent/CA2673277A1/en not_active Abandoned
- 2007-12-20 EA EA200900658A patent/EA016895B1/ru not_active IP Right Cessation
- 2007-12-21 CL CL200703804A patent/CL2007003804A1/es unknown
- 2007-12-21 AR ARP070105870A patent/AR064505A1/es not_active Application Discontinuation
- 2007-12-29 SA SA7280740A patent/SA07280740B1/ar unknown
-
2008
- 2008-01-02 PE PE2008000011A patent/PE20081838A1/es not_active Application Discontinuation
-
2009
- 2009-05-21 IL IL198880A patent/IL198880A/en not_active IP Right Cessation
- 2009-05-26 ZA ZA2009/03654A patent/ZA200903654B/en unknown
- 2009-06-19 SV SV2009003305A patent/SV2009003305A/es active IP Right Grant
- 2009-06-19 TN TNP2009000250A patent/TN2009000250A1/fr unknown
- 2009-06-19 GT GT200900175A patent/GT200900175A/es unknown
- 2009-06-19 CR CR10875A patent/CR10875A/es unknown
- 2009-06-19 DO DO2009000148A patent/DOP2009000148A/es unknown
- 2009-06-23 EC EC2009009452A patent/ECSP099452A/es unknown
- 2009-07-09 MA MA32078A patent/MA31087B1/fr unknown
- 2009-07-17 NO NO20092723A patent/NO20092723L/no not_active Application Discontinuation
- 2009-12-21 US US12/643,504 patent/US20100197644A1/en not_active Abandoned
-
2010
- 2010-12-02 US US12/959,027 patent/US8143290B2/en not_active Expired - Fee Related
-
2012
- 2012-03-23 US US13/429,177 patent/US20120252770A1/en not_active Abandoned
- 2012-08-13 CY CY20121100730T patent/CY1113269T1/el unknown
- 2012-08-23 JP JP2012184346A patent/JP2012224647A/ja active Pending